2020 年 11 月至 2021 年 10 月期间，严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）B.1.617.2（德尔塔变体）流行期间，有症状的 2019 年冠状病毒病（COVID-19）患者死亡率增加：阿拉斯加。
Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020-October 2021.
机构信息
CDC COVID-19 Response, Anchorage, Alaska, USA.
Epidemic Intelligence Service Officer, Anchorage, Alaska, USA.
出版信息
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S298-S302. doi: 10.1093/cid/ciac530.
Abstract
We compared the mortality risk in Alaska among persons with symptomatic coronavirus disease 2019 (COVID-19) during the period the Delta variant was predominant to the risk among those with symptomatic COVID-19 before Delta predominance. The Delta period was associated with 2.43-fold higher odds of death. Unvaccinated persons were 4.49 times more likely to die than fully vaccinated persons.
摘要
我们比较了德尔塔变异株占主导地位期间，阿拉斯加有症状的 2019 冠状病毒病（COVID-19）患者的死亡风险与德尔塔变异株占主导地位之前有症状 COVID-19 患者的死亡风险。德尔塔变异株期与死亡风险增加 2.43 倍相关。与完全接种疫苗的人相比，未接种疫苗的人死亡的可能性高出 4.49 倍。
相似文献
1
Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020-October 2021.2020 年 11 月至 2021 年 10 月期间，严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）B.1.617.2（德尔塔变体）流行期间，有症状的 2019 年冠状病毒病（COVID-19）患者死亡率增加：阿拉斯加。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S298-S302. doi: 10.1093/cid/ciac530.
2
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州，2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
3
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
4
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.2020 年 12 月-2021 年 11 月，美国养老院居民在德尔塔变异株流行前后，接种 2019 冠状病毒病（COVID-19）疫苗对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的效果。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S147-S154. doi: 10.1093/cid/ciac562.
5
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
6
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET，14 个州，2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.
7
Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status-United States, 1 January 2020-25 December 2021.2020 年 1 月 1 日至 2021 年 12 月 25 日，美国妊娠状态下有症状且经实验室确认的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的育龄妇女的 2019 年冠状病毒病（COVID-19）严重程度。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S317-S325. doi: 10.1093/cid/ciac479.
8
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021.2021 年 3 月至 7 月，加利福尼亚州大型综合医疗保健系统中 SARS-CoV-2 变异株的分布情况。
MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1415-1419. doi: 10.15585/mmwr.mm7040a4.
9
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.接种 COVID-19 疫苗与接种后时间和德尔塔变异株流行对有症状 SARS-CoV-2 感染的关联。
JAMA. 2022 Mar 15;327(11):1032-1041. doi: 10.1001/jama.2022.2068.
10
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.在卡塔尔感染 SARS-CoV-2 的德尔塔变异株和贝塔变异株患者的疾病严重程度。
JAMA Intern Med. 2022 Feb 1;182(2):197-205. doi: 10.1001/jamainternmed.2021.7949.
Zotero 插件